[Skip to Content]
[Skip to Content Landing]
Article
December 13, 1976

Successful Protection of Humans Exposed to Rabies Infection: Postexposure Treatment With the New Human Diploid Cell Rabies Vaccine and Antirabies Serum

Author Affiliations

From the Institut Pasteur de l'Iran, World Health Organization Collaborating Center for Reference and Research in Rabies, Tehran (Drs Bahmanyar, Fayaz, Nour-Salehi, and Mohammadi); and The Wistar Institute of Anatomy and Biology, World Health Organization Collaborating Center for Reference and Research in Rabies, Philadelphia (Dr Koprowski).

JAMA. 1976;236(24):2751-2754. doi:10.1001/jama.1976.03270250019017
Abstract

Forty-five persons severely bitten by rabid dogs and wolves in Iran were treated after exposure with a new rabies vaccine produced in cultures of human diploid cells. All except one also received one injection of rabies immune serum. This treatment, in contrast to past experience with other vaccines, resulted in protection of all individuals against rabies. Thus, almost a century after the postexposure treatment of humans was initiated, an effective tool for protecting man against rabies has finally been developed.

(JAMA 236:2751-2754, 1976)

×